AU6423494A - Pharmaceutical composition for the prevention of neuronal cell death - Google Patents

Pharmaceutical composition for the prevention of neuronal cell death

Info

Publication number
AU6423494A
AU6423494A AU64234/94A AU6423494A AU6423494A AU 6423494 A AU6423494 A AU 6423494A AU 64234/94 A AU64234/94 A AU 64234/94A AU 6423494 A AU6423494 A AU 6423494A AU 6423494 A AU6423494 A AU 6423494A
Authority
AU
Australia
Prior art keywords
prevention
pharmaceutical composition
cell death
neuronal cell
neuronal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64234/94A
Inventor
Lars Dalgaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU6423494A publication Critical patent/AU6423494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU64234/94A 1993-03-30 1994-03-09 Pharmaceutical composition for the prevention of neuronal cell death Abandoned AU6423494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK373/93 1993-03-30
DK37393A DK37393D0 (en) 1993-03-30 1993-03-30
PCT/DK1994/000101 WO1994022446A1 (en) 1993-03-30 1994-03-09 Pharmaceutical composition for the prevention of neuronal cell death

Publications (1)

Publication Number Publication Date
AU6423494A true AU6423494A (en) 1994-10-24

Family

ID=8092780

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64234/94A Abandoned AU6423494A (en) 1993-03-30 1994-03-09 Pharmaceutical composition for the prevention of neuronal cell death

Country Status (3)

Country Link
AU (1) AU6423494A (en)
DK (1) DK37393D0 (en)
WO (1) WO1994022446A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002035987A2 (en) * 2000-11-03 2002-05-10 Massachusetts Institute Of Technology METHODS FOR IDENTIFYING TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE CAUSED BY β-AMYLOID PEPTIDES

Also Published As

Publication number Publication date
DK37393D0 (en) 1993-03-30
WO1994022446A1 (en) 1994-10-13

Similar Documents

Publication Publication Date Title
AU6437394A (en) Thiazolidine derivative and pharmaceutical composition containing the same
AU1396395A (en) Farnesyl derivatives and pharmaceutical compositions containing them
HU9402974D0 (en) Pharmaceutical composition
IL110743A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL110988A0 (en) 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
AU7707194A (en) Azole derivative and pharmaceutical composition thereof
AU3716193A (en) Pharmaceutical compositions
AU7961094A (en) Picosulphate dosage form
AU7508494A (en) Benzazepine derivative, pharmaceutical composition containing the same, and intermediate for the same
AU5100393A (en) Diindolo compounds and pharmaceutical compositions containing them
ZA945930B (en) Pharmaceutical composition
AU6983894A (en) Thiazolidine derivative and medicine containing the same
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same
AU3542993A (en) Pharmaceutical compounds
ZA941088B (en) Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them
AU7275894A (en) Imidazolylalkylamine derivative and pharmaceutical composition thereof
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
AU6774694A (en) Taste-masking pharmaceutical compositions and methods for making the same
PL314036A1 (en) Pharmaceutical composition
CA2100836A1 (en) Pharmaceutical Composition
AU6690394A (en) Imidazolylquinoxalinedione derivative and pharmaceutical composition thereof
ZA945752B (en) Pharmaceutical composition
AU6423494A (en) Pharmaceutical composition for the prevention of neuronal cell death
GB9318880D0 (en) Pharmaceutical composition
AU5626494A (en) Nitroxy compounds with pharmaceutical properties